Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Escalier Biosciences brings in $19mm through Series B round

Executive Summary

Escalier Biosciences BV (RORyt (retinoic acid receptor-related orphan receptor gamma) compounds for dermatology and auto-immune conditions) closed a $19mm Series B round led by new backer Forbion (adds one of its partners to Escalier's board), which was joined by returning investors New Science Ventures and BioGeneration Ventures (BGV).
Deal Industry
  • Biotechnology
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
      • Topical Delivery
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies